Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE15.5400
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots12.4900/ 1
- Ask / Lots18.5300/ 1
- Open / Previous Close0.0000 / 15.5400
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 6130 | 15.85 |
| 09:34 ET | 2162 | 15.57 |
| 09:36 ET | 2474 | 15.27 |
| 09:38 ET | 1460 | 15.23 |
| 09:39 ET | 200 | 15.18 |
| 09:41 ET | 885 | 15.235 |
| 09:43 ET | 1800 | 15.305 |
| 09:45 ET | 1629 | 15.26 |
| 09:48 ET | 1095 | 15.13 |
| 09:50 ET | 300 | 15.16 |
| 09:52 ET | 1257 | 15.225 |
| 09:54 ET | 200 | 15.24 |
| 09:56 ET | 700 | 15.1 |
| 09:57 ET | 1590 | 15.14 |
| 09:59 ET | 2497 | 15.02 |
| 10:01 ET | 6777 | 15.05 |
| 10:03 ET | 772 | 15.02 |
| 10:06 ET | 2567 | 15.085 |
| 10:08 ET | 3327 | 15.01 |
| 10:10 ET | 9212 | 14.97 |
| 10:12 ET | 2327 | 15.02 |
| 10:14 ET | 1300 | 15.165 |
| 10:19 ET | 1336 | 15.34 |
| 10:21 ET | 947 | 15.38 |
| 10:24 ET | 700 | 15.41 |
| 10:26 ET | 7688 | 15.36 |
| 10:28 ET | 5689 | 15.2 |
| 10:30 ET | 500 | 15.18 |
| 10:32 ET | 787 | 15.193 |
| 10:33 ET | 1469 | 15.135 |
| 10:35 ET | 2500 | 15.2 |
| 10:39 ET | 647 | 15.18 |
| 10:42 ET | 1141 | 15.195 |
| 10:44 ET | 100 | 15.195 |
| 10:50 ET | 211 | 15.25 |
| 10:51 ET | 108 | 15.26 |
| 10:53 ET | 1198 | 15.2 |
| 10:55 ET | 800 | 15.1 |
| 11:00 ET | 300 | 15.05 |
| 11:02 ET | 300 | 15.05 |
| 11:04 ET | 2500 | 15.03 |
| 11:08 ET | 400 | 15.05 |
| 11:09 ET | 700 | 15.07 |
| 11:11 ET | 100 | 15.115 |
| 11:13 ET | 100 | 15.11 |
| 11:15 ET | 1340 | 15.17 |
| 11:18 ET | 1363 | 15.18 |
| 11:20 ET | 1817 | 15.165 |
| 11:31 ET | 100 | 15.22 |
| 11:33 ET | 3267 | 15.13 |
| 11:36 ET | 400 | 15.1 |
| 11:38 ET | 100 | 15.07 |
| 11:40 ET | 2800 | 15.195 |
| 11:42 ET | 400 | 15.245 |
| 11:44 ET | 727 | 15.24 |
| 11:49 ET | 700 | 15.18 |
| 11:58 ET | 509 | 15.18 |
| 12:00 ET | 500 | 15.14 |
| 12:02 ET | 200 | 15.12 |
| 12:03 ET | 2435 | 15.16 |
| 12:05 ET | 1000 | 15.15 |
| 12:07 ET | 758 | 15.131 |
| 12:09 ET | 300 | 15.11 |
| 12:14 ET | 2144 | 15.2 |
| 12:16 ET | 900 | 15.17 |
| 12:20 ET | 1701 | 15.105 |
| 12:21 ET | 1345 | 15.15 |
| 12:23 ET | 200 | 15.12 |
| 12:27 ET | 200 | 15.11 |
| 12:30 ET | 200 | 15.1 |
| 12:32 ET | 614 | 15.09 |
| 12:34 ET | 3104 | 15.11 |
| 12:36 ET | 600 | 15.085 |
| 12:38 ET | 651 | 15.11 |
| 12:39 ET | 1400 | 15.1 |
| 12:41 ET | 1922 | 15.165 |
| 12:43 ET | 1919 | 15.24 |
| 12:45 ET | 100 | 15.24 |
| 12:48 ET | 2542 | 15.27 |
| 12:50 ET | 200 | 15.2825 |
| 12:52 ET | 1645 | 15.26 |
| 12:54 ET | 700 | 15.285 |
| 12:56 ET | 500 | 15.285 |
| 12:57 ET | 644 | 15.27 |
| 01:01 ET | 200 | 15.26 |
| 01:03 ET | 3472 | 15.29 |
| 01:06 ET | 100 | 15.32 |
| 01:08 ET | 200 | 15.32 |
| 01:10 ET | 594 | 15.37 |
| 01:12 ET | 200 | 15.36 |
| 01:14 ET | 200 | 15.35 |
| 01:15 ET | 2851 | 15.265 |
| 01:17 ET | 200 | 15.26 |
| 01:21 ET | 1341 | 15.26 |
| 01:24 ET | 400 | 15.28 |
| 01:26 ET | 300 | 15.26 |
| 01:28 ET | 315 | 15.255 |
| 01:30 ET | 200 | 15.255 |
| 01:32 ET | 2447 | 15.29 |
| 01:33 ET | 222 | 15.3 |
| 01:35 ET | 400 | 15.325 |
| 01:37 ET | 700 | 15.32 |
| 01:42 ET | 661 | 15.29 |
| 01:44 ET | 550 | 15.29 |
| 01:46 ET | 249 | 15.3 |
| 01:48 ET | 4198 | 15.37 |
| 01:50 ET | 200 | 15.38 |
| 01:51 ET | 900 | 15.41 |
| 01:53 ET | 1240 | 15.32 |
| 01:55 ET | 100 | 15.32 |
| 01:57 ET | 200 | 15.32 |
| 02:00 ET | 923 | 15.325 |
| 02:02 ET | 500 | 15.32 |
| 02:06 ET | 1255 | 15.355 |
| 02:09 ET | 2258 | 15.42 |
| 02:11 ET | 200 | 15.43 |
| 02:13 ET | 100 | 15.415 |
| 02:15 ET | 200 | 15.415 |
| 02:18 ET | 2150 | 15.37 |
| 02:20 ET | 657 | 15.34 |
| 02:24 ET | 200 | 15.33 |
| 02:26 ET | 1050 | 15.33 |
| 02:27 ET | 300 | 15.34 |
| 02:29 ET | 200 | 15.335 |
| 02:31 ET | 2190 | 15.336 |
| 02:33 ET | 300 | 15.32 |
| 02:36 ET | 120 | 15.3063 |
| 02:38 ET | 512 | 15.28 |
| 02:40 ET | 100 | 15.28 |
| 02:42 ET | 2073 | 15.345 |
| 02:45 ET | 1133 | 15.39 |
| 02:47 ET | 1590 | 15.36 |
| 02:49 ET | 100 | 15.365 |
| 02:51 ET | 300 | 15.38 |
| 02:54 ET | 800 | 15.43 |
| 02:56 ET | 1902 | 15.465 |
| 02:58 ET | 700 | 15.49 |
| 03:00 ET | 1300 | 15.46 |
| 03:02 ET | 500 | 15.48 |
| 03:03 ET | 1058 | 15.48 |
| 03:05 ET | 946 | 15.54 |
| 03:07 ET | 606 | 15.555 |
| 03:09 ET | 3171 | 15.535 |
| 03:12 ET | 600 | 15.53 |
| 03:14 ET | 1798 | 15.48 |
| 03:16 ET | 2968 | 15.475 |
| 03:20 ET | 1502 | 15.5 |
| 03:21 ET | 1379 | 15.49 |
| 03:23 ET | 4600 | 15.54 |
| 03:25 ET | 3923 | 15.53 |
| 03:27 ET | 500 | 15.53 |
| 03:30 ET | 2396 | 15.51 |
| 03:32 ET | 2907 | 15.55 |
| 03:34 ET | 9042 | 15.63 |
| 03:36 ET | 1221 | 15.63 |
| 03:38 ET | 2286 | 15.59 |
| 03:39 ET | 600 | 15.58 |
| 03:41 ET | 3915 | 15.645 |
| 03:43 ET | 4284 | 15.67 |
| 03:45 ET | 1531 | 15.75 |
| 03:48 ET | 2883 | 15.725 |
| 03:50 ET | 2828 | 15.73 |
| 03:52 ET | 2682 | 15.76 |
| 03:54 ET | 10353 | 15.71 |
| 03:56 ET | 7968 | 15.59 |
| 03:57 ET | 10478 | 15.575 |
| 03:59 ET | 17929 | 15.54 |
Yesterday
Nurix Therapeutics Appoints Paula G. O'Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer, from 22 hours ago by Dow Jones
22 hours ago by Dow JonesPress Release: Nurix Therapeutics Appoints Paula G. O'Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer, from 22 hours ago by Dow Jones
22 hours ago by Dow Jones
May 20, 2024
DJ Nurix Therapeutics Names Julia Gregory As New Chair, from 4:11PM ET on Monday May 20, 2024 by Dow Jones
4:11PM ET on Monday May 20, 2024 by Dow JonesNurix Therapeutics Announces Board Chair Transition, from 4:00PM ET on Monday May 20, 2024 by Dow Jones
4:00PM ET on Monday May 20, 2024 by Dow JonesPress Release: Nurix Therapeutics Announces Board Chair Transition, from 4:00PM ET on Monday May 20, 2024 by Dow Jones
4:00PM ET on Monday May 20, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 921.6M | -5.9x | --- |
CureVac NV | 823.2M | -2.8x | --- |
Arcutis Biotherapeutics Inc | 1.0B | -3.0x | --- |
Prothena Corporation PLC | 1.1B | -6.1x | --- |
SAGE Therapeutics Inc | 718.0M | -1.4x | --- |
Regenxbio Inc | 736.9M | -2.5x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Scientific Officer
- Gwenn Hansen
- Chief Legal Officer, Chief Compliance Officer, Secretary
- Christine Ring
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $921.6M |
|---|---|
Revenue (TTM) | $80.9M |
Shares Outstanding | 59.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.17 |
EPS | $-2.65 |
Book Value | $4.12 |
P/E Ratio | -5.9x |
Price/Sales (TTM) | 11.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -194.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
